Glen Pearson, BSc, BScPhm, PharmD, FSCHP, FCCS

Area of Study / Keywords

CV surgery Cardiac Transplant Outcomes Research Pharmacotherapy Dyslipidemia Cardiovascular Risk Reduction

---

About

Personal Statement:

I have always been drawn to non-traditional health care provider roles and the possibilities to expand the clinical boundaries of the profession of pharmacy. Being a practitioner in cardiac transplantation and cardiology allows me to work across the spectrum of patient care, acute care, chronic conditions, end-of-life. I love to work through the challenges of complex diseases and see the results of my interventions realized in excellent patient outcomes and an improved quality of life.

Dr. Glen Pearson obtained a Bachelor of Science degree in Biology from the University of Western Ontario and both his Bachelor of Science in Pharmacy (Cum Laude) and Doctor of Pharmacy (Cum Laude) degrees from the Philadelphia College of Pharmacy & Science. He was recruited to the University of Alberta in 2001. 

Leadership and Collaborations:

Dr. Pearson is the co-director of the Cardiac Transplant Clinic and Chair of the Health Research Ethics Board (HREB) Biomedical Panel for the University of Alberta. He was a member of the Expert Committee on Drug Evaluation and Therapeutics for Alberta Health. Dr. Pearson is an active member of the Canadian Cardiology Pharmacists Network and the Canadian Cardiovascular Society (CCS). He has been a member of the CCS Canadian Dyslipidemia Guidelines primary panel since 2009 and is currently the Chair for the 2021 CCS Dyslipidemia Guidelines update. He was a primary panel member of the CCS 2018 CCS Position Statement on Familial Hypercholesterolemia (FH) and a member of the new FH Canada Registry practitioner initiative. He is also a primary member of the Canadian Working Group for the Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance.

He is a former president of both the Canadian Society of Hospital Pharmacists and the Canadian College of Clinical Pharmacy. He has been recognized for his both his clinical and leadership contributions thorough the receipt of numerous awards, including: the M.J. Houston Pharmacist of the Year Award from Alberta College of Pharmacists and the Alberta Pharmacists’ Association (2008), Alberta Pharmacy Centennial Award of Distinction (2011), APEX Partners in Practice Award for collaborative efforts to optimize patient care and safety in the University of Alberta/Mazankowski Alberta Heart Institute Cardiac Transplant Team (2011), Canadian Society of Hospital Pharmacists Pharmacotherapy Best Practices Award (2012/13), and a special recognition in 2008 for the achievement in becoming one of the first fifteen pharmacists in Canada to be granted additional prescribing authorization. He has also been conferred recognition with fellowship status in both the Canadian Society of Hospital Pharmacists and the Canadian Cardiovascular Society.

Global Edmonton Interview: Guidebook for Pharmacists on Diabetes Management: https://vimeo.com/107924655

Clinical Interests

Dr. Pearson is an advanced cardiovascular pharmacotherapy practitioner who treats cardiac and cardiac transplant patients in the Mazankowski Alberta Heart Institute as part of a collaborative care team.

---

Research

In addition to Dr. Pearson’s clinical research focused on assessing therapies, screening, diagnoses and care for cardiac and such associated conditions as cholesterol, he studies the role of pharmacists in patient disease management. A 2016 study Pearson led showed a three-fold increase in patients meeting their cholesterol level targets when pharmacists prescribed medications, ordered tests and explained test results. The study results were published in the Canadian Pharmacists Journal. He is author or co-author of publications resulting from numerous research projects including studies of familial hypercholesterolemia, published in the journal of the College of Family Physicians of Canada, of lipid-lowering agents published in the Canadian Journal of Cardiology, and of the evolving profession of pharmacy published in the Canadian Medical Association Journal. He was involved in the 2018 update to the Canadian Cardiovascular Harmonized National Guidelines Endeavour for the prevention and management of cardiovascular disease in primary care.

---

Teaching

Dr. Pearson currently teaches in the Cardio-Renal Block of the first Medical Practice course for medical and dental students. He also provides a number of lectures in cardiovascular pharmacotherapeutics to the both the undergraduate and graduate health professions students at the University of Alberta. He supervises post-doctoral (PharmD) students in clinical rotations (form UBC, UofT, and UofA) and has established clinical fellowship programs in ambulatory cardiovascular practice and multi-organ transplant practice through the Department of Medicine at the University of Alberta. Recently, he has co-developed the first Canadian advanced specialty residency program in Cardiology (PGY2-Cardiology) in collaboration with the Division of Cardiology and Alberta Health Services. In addition, he supervises MSc students in the Masters in Medicine program.

Diabetes Obes Metab . 2024 May;

---

Dennis J. Orton, Jessica L. Gifford, Joshua E. Raizman, Glen J. Pearson, Albert K.Y. Tsui

Canadian Journal of Cardiology. 2024 March; 10.1016/j.cjca.2024.02.019

---

Hazal Babadagli, Sheri Koshman, Michelle Graham, Glen Pearson

Canadian Journal of Hospital Pharmacy. 2024 February; 10.4212/cjhp.3472

---

Tiffany Yuen, G. B. John Mancini, Robert A. Hegele, Glen J. Pearson

CJC Open. 2023 November; 10.1016/j.cjco.2023.11.015

---

Gordon A. Francis, George Thanassoulis, Glen J. Pearson

Canadian Journal of Cardiology. 2023 November; 10.1016/j.cjca.2023.11.012

---

Hazal E. Babadagli, Arden R. Barry, George Thanassoulis, Glen J. Pearson

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2023 May; 10.1177/17151635231164989

---

2023 January; 10.1503/cmaj.220138-f

---

2022 November; 10.1503/cmaj.220138

---

Barry A.R., Bishop K.E., Pearson G.J., Koshman S.L.

Canadian Pharmacists Journal (CPJ). 2022 May; 155 (3):169-174 10.1177/17151635221087639

---

Barry AR, Pearson GJ

Pharmacy Practice + Business. 2021 September; 8 (6):20-24 https://issuu.com/ensembleiq/docs/ppb-0921?fr=sZGY

---

Thanassoulis G, Anderson TJ, Barry AR,Couture P, Dayan N, Francis GA, Genest J, Grégoire J, Grover SA, Gupta M, Hegele RA, Lau D, Leiter LA, Leung AA, Lonn E, Mancini GBJ, Manjoo P, McPherson R, Ngui D, Piché ME, Poirier P, Sievenpiper J, Stone J, Ward R, Wray W.

CANADIAN JOURNAL OF CARDIOLOGY. 2021 August; 37 10.1016/j.cjca.2021.03.016

---

Ackman M.L., Koshman S., Pearson G.J., Semchuk W., Shamiss Y., Thompson A., Warner T.

Canadian Pharmacists Journal [Can Pharm J (Ott)]. 2021 May; 154 (3):175-178 10.1177/17151635211006166

---

2020 February; 10.1002/phar.2359

---

2019 October; 10.1016/j.cjco.2019.09.001

---

View additional publications